World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
66317
World Ranking
7488
National Ranking
3915

Gary E. Raskob publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Gary E. Raskob sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 334 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Gary E. Raskob D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Gary E. Raskob sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 102 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Gary E. Raskob is affiliated with the University of Oklahoma Health Sciences Center in the United States. Their research focuses on medicine, with particular expertise in cardiology and cardiovascular medicine, internal medicine, hematology, surgery, and emergency medical services.

The central topics of their work include:

  • Venous thromboembolism diagnosis and management
  • Atrial fibrillation management and outcomes
  • Acute myocardial infarction research
  • Blood coagulation and thrombosis mechanisms
  • Diagnosis and treatment of venous diseases
  • Antiplatelet therapy and cardiovascular diseases
  • Central venous catheters and hemodialysis

Gary E. Raskob has contributed to numerous publications in several journals, with frequent appearances in:

  • Thrombosis and Haemostasis
  • Journal of Thrombosis and Haemostasis
  • TH Open
  • The Oncologist
  • Journal of the American Heart Association

Their notable recent papers include:

  • Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty, 2020, JAMA
  • Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended Thromboprophylaxis, 2020, TH Open
  • Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism, 2021, Annals of Internal Medicine
  • Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score, 2023, European Heart Journal
  • Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients, 2020, Journal of the American College of Cardiology

The researcher frequently collaborates with other scientists, including:

  • Jeffrey I. Weitz
  • Alex C. Spyropoulos
  • Elliot S. Barnathan
  • Theodore E. Spiro
  • Walter Ageno

Best Publications

  • Oral rivaroxaban for symptomatic venous thromboembolism

    Rupert Bauersachs;Scott D. Berkowitz;Benjamin Brenner;Harry R. Buller

  • Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

    Barry F. Jacobson;Erich Minar;Jaromir Chlumsky;Peter Verhamme

  • Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

    Clive Kearon;Susan R. Kahn;Giancarlo Agnelli;Samuel Goldhaber

  • Oral Apixaban for the Treatment of Acute Venous Thromboembolism

    Giancarlo Agnelli;Harry R. Buller;Alexander Cohen;Madelyn Curto

  • Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

    Harry R. Büller;Hervé Décousus;Michael A. Grosso;Saskia Middeldorp

  • Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.

    JN George;SH Woolf;GE Raskob;JS Wasser

  • Antithrombotic Therapy for Venous Thromboembolic Disease : The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

    Harry R. Büller;Giancarlo Agnelli;Russel D. Hull;Thomas M. Hyers

  • Apixaban for Extended Treatment of Venous Thromboembolism

    Giancarlo Agnelli;Harry R. Buller;Alexander Cohen;Madelyn Curto

  • Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

    Gary E. Raskob;Nick van Es;Peter Verhamme;Marc Carrier

  • Grading Strength of Recommendations and Quality of Evidence in Clinical Guidelines: Report From an American College of Chest Physicians Task Force

    Gordon Guyatt;David Gutterman;Michael H. Baumann;Doreen Addrizzo-Harris

  • Pulmonary Arterial Hypertension : Baseline Characteristics From the REVEAL Registry

    David B. Badesch;Gary E. Raskob;C. Greg Elliott;Abby M. Krichman

  • American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer

    Gary H. Lyman;Alok A. Khorana;Anna Falanga;Daniel Clarke-Pearson

  • Thrombosis A Major Contributor to Global Disease Burden

    G.E. Raskob;P. Angchaisuksiri;A.N. Blanco;H. Buller

  • Global Burden of Thrombosis: Epidemiologic Aspects.

    Aaron M. Wendelboe;Gary E. Raskob

  • Hemorrhagic Complications of Anticoagulant Treatment

    Mark N. Levine;Gary Raskob;Seth Landefeld;Clive Kearon

  • Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

    Michael Rud Lassen;Gary E Raskob;Alexander Gallus;Graham Pineo

  • Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis.

    Hull Rd;Raskob Ge;Pineo Gf;Green D

  • Apixaban or enoxaparin for thromboprophylaxis after knee replacement.

    Michael Rud Lassen;Gary E. Raskob;Alexander Gallus;Graham Pineo

  • Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.

    R D Hull;G E Raskob;J Hirsh;R M Jay

  • Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement

    Michael R Lassen;Alexander Stephen Gallus;Gary E. Raskob;Graham F Pineo

Frequent Co-Authors

Russell D. Hull
Russell D. Hull University of Calgary
Harry R. Büller
Harry R. Büller University of Amsterdam
Jeffrey I. Weitz
Jeffrey I. Weitz McMaster University
Alexander G.G. Turpie
Alexander G.G. Turpie McMaster University
Ajay K. Kakkar
Ajay K. Kakkar University College London
Paolo Prandoni
Paolo Prandoni University of Padua
Jack Hirsh
Jack Hirsh McMaster University
David Bergqvist
David Bergqvist Uppsala University
Samuel Z. Goldhaber
Samuel Z. Goldhaber Brigham and Women's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative degrees and pathways in healthcare can open new doors, whether or not you ultimately pursue medical school. Several high-demand fields offer flexible online routes to advance your career, build expertise, or pivot into related roles.

A rapidly growing option is an online bachelor's degree in nutrition. This program is ideal for those interested in science and wellness, paving the way for roles in dietetics, public health, or health coaching.

If you're interested in leadership roles, consider the top cahme-accredited mha programs, which develop business and managerial skills for healthcare administration careers.

Licensed nurses looking to advance may appreciate the flexibility of rn to bsn no clinical hours programs, allowing registered nurses to earn their Bachelor of Science in Nursing online, often without additional clinical requirements.

For advanced nursing professionals, a 1 year dnp program online offers a fast-track option to a Doctor of Nursing Practice, elevating clinical expertise and opening leadership or teaching opportunities.

These online healthcare degrees empower students to upskill, transition, and excel in a range of rewarding medical and allied health careers.

Best Scientists Citing Gary E. Raskob

Trending Scientists

Recently Published Articles